{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"156","value":"1.48"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"78"}],"units":"Participants"}],"description":"Cmax is the maximum (peak) observed in peripheral blood after single dose administration. Actual sampling times were taken into consideration for the calculation of cellular kinetic parameters parameters.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"All participants who were enrolled in the study","id":"OG000","title":"CTL019"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Participants in the Cellular kinetic set (CKAS) with an available value for the outcome measure. The CKAS consisted of patients in the Efficacy analysis set who provided an evaluable cellular kinetic profile (at least 1 cellular kinetic parameter).","reportingStatus":"POSTED","timeFrame":"From pre-dose until 60 months after infusion","title":"Cmax; Cellular Kinetic Parameter for Tisagenlecleucel by Flow Cytometry, Based on Clinical Response by IRC Assessment","type":"SECONDARY","unitOfMeasure":"percentage of cells"}